Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

According to the American Association for the Study of Liver Diseases (AASLD) treatment
guidelines for hepatocellular carcinoma (HCC), the role of surgery has been expanded …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Portal vein tumor thrombus (PVTT) is a significant poor prognostic factor for hepatocellular
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Background The ideal management for patients with intermediate and advanced stage
hepatocellular carcinoma (HCC) is controversial. The main purpose of this systematic review …

Abstract Background & Aims Portal vein tumour thrombosis (PVTT) has a significant impact
on the prognosis of patients with hepatocellular carcinoma (HCC). The degree of PVTT …

Purpose To compare the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) to transarterial chemoembolization/embolization (TACE/TAE) for the treatment of …

Portal vein tumor thrombus is a frequent, challenging complication in hepatocellular
carcinoma. Hepatocellular carcinoma patients with portal vein tumor thrombus may show …